Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance

Abstract Osteosarcoma is the most prevalent and fatal type of bone tumor. Despite advancements in the treatment of other cancers, overall survival rates for patients with osteosarcoma have stagnated over the past four decades Multiple-drug resistance—the capacity of cancer cells to become simultaneo...

Full description

Bibliographic Details
Main Authors: Shuang Qin, Yuting Wang, Chunhui Ma, Qi Lv
Format: Article
Language:English
Published: BMC 2023-09-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-023-01309-x
_version_ 1797577296240967680
author Shuang Qin
Yuting Wang
Chunhui Ma
Qi Lv
author_facet Shuang Qin
Yuting Wang
Chunhui Ma
Qi Lv
author_sort Shuang Qin
collection DOAJ
description Abstract Osteosarcoma is the most prevalent and fatal type of bone tumor. Despite advancements in the treatment of other cancers, overall survival rates for patients with osteosarcoma have stagnated over the past four decades Multiple-drug resistance—the capacity of cancer cells to become simultaneously resistant to multiple drugs—remains a significant obstacle to effective chemotherapy. The recent studies have shown that noncoding RNAs can regulate the expression of target genes. It has been proposed that “competing endogenous RNA” activity forms a large-scale regulatory network across the transcriptome, playing important roles in pathological conditions such as cancer. Numerous studies have highlighted that circular RNAs (circRNAs) and long noncoding RNAs (lncRNAs) can bind to microRNA (miRNA) sites as competitive endogenous RNAs, thereby affecting and regulating the expression of mRNAs and target genes. These circRNA/lncRNA-associated competitive endogenous RNAs are hypothesized to play significant roles in cancer initiation and progression. Noncoding RNAs (ncRNAs) play an important role in tumor resistance to chemotherapy. However, the molecular mechanisms of the lncRNA/circRNA-miRNA-mRNA competitive endogenous RNA network in drug resistance of osteosarcoma remain unclear. An in-depth study of the molecular mechanisms of drug resistance in osteosarcoma and the elucidation of effective intervention targets are of great significance for improving the overall recovery of patients with osteosarcoma. This review focuses on the molecular mechanisms underlying chemotherapy resistance in osteosarcoma in circRNA-, lncRNA-, and miRNA-mediated competitive endogenous networks.
first_indexed 2024-03-10T22:06:15Z
format Article
id doaj.art-51ccf9eaab7346b696cf11f0b4c8933a
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-03-10T22:06:15Z
publishDate 2023-09-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-51ccf9eaab7346b696cf11f0b4c8933a2023-11-19T12:46:48ZengBMCEuropean Journal of Medical Research2047-783X2023-09-012811910.1186/s40001-023-01309-xCompetitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistanceShuang Qin0Yuting Wang1Chunhui Ma2Qi Lv3Department of Medical Imaging, Tongji Hospital, Tongji University School of MedicineDepartment of Medical Imaging, Tongji Hospital, Tongji University School of MedicineDepartment of Orthopedics, Shanghai General Hospital of Shanghai Jiaotong UniversityDepartment of Medical Imaging, Tongji Hospital, Tongji University School of MedicineAbstract Osteosarcoma is the most prevalent and fatal type of bone tumor. Despite advancements in the treatment of other cancers, overall survival rates for patients with osteosarcoma have stagnated over the past four decades Multiple-drug resistance—the capacity of cancer cells to become simultaneously resistant to multiple drugs—remains a significant obstacle to effective chemotherapy. The recent studies have shown that noncoding RNAs can regulate the expression of target genes. It has been proposed that “competing endogenous RNA” activity forms a large-scale regulatory network across the transcriptome, playing important roles in pathological conditions such as cancer. Numerous studies have highlighted that circular RNAs (circRNAs) and long noncoding RNAs (lncRNAs) can bind to microRNA (miRNA) sites as competitive endogenous RNAs, thereby affecting and regulating the expression of mRNAs and target genes. These circRNA/lncRNA-associated competitive endogenous RNAs are hypothesized to play significant roles in cancer initiation and progression. Noncoding RNAs (ncRNAs) play an important role in tumor resistance to chemotherapy. However, the molecular mechanisms of the lncRNA/circRNA-miRNA-mRNA competitive endogenous RNA network in drug resistance of osteosarcoma remain unclear. An in-depth study of the molecular mechanisms of drug resistance in osteosarcoma and the elucidation of effective intervention targets are of great significance for improving the overall recovery of patients with osteosarcoma. This review focuses on the molecular mechanisms underlying chemotherapy resistance in osteosarcoma in circRNA-, lncRNA-, and miRNA-mediated competitive endogenous networks.https://doi.org/10.1186/s40001-023-01309-xOsteosarcomaCircRNALncRNAmiRNACompetitive endogenous RNAChemotherapy resistance
spellingShingle Shuang Qin
Yuting Wang
Chunhui Ma
Qi Lv
Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
European Journal of Medical Research
Osteosarcoma
CircRNA
LncRNA
miRNA
Competitive endogenous RNA
Chemotherapy resistance
title Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
title_full Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
title_fullStr Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
title_full_unstemmed Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
title_short Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
title_sort competitive endogenous network of circrna lncrna and mirna in osteosarcoma chemoresistance
topic Osteosarcoma
CircRNA
LncRNA
miRNA
Competitive endogenous RNA
Chemotherapy resistance
url https://doi.org/10.1186/s40001-023-01309-x
work_keys_str_mv AT shuangqin competitiveendogenousnetworkofcircrnalncrnaandmirnainosteosarcomachemoresistance
AT yutingwang competitiveendogenousnetworkofcircrnalncrnaandmirnainosteosarcomachemoresistance
AT chunhuima competitiveendogenousnetworkofcircrnalncrnaandmirnainosteosarcomachemoresistance
AT qilv competitiveendogenousnetworkofcircrnalncrnaandmirnainosteosarcomachemoresistance